文献速递血栓与止血

非肌性肌球蛋白IIA突变导致巨核细胞迁移缺陷进而引发MYH9相关疾病中的血小板减少

Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.
PubMed 文献 · Blood · 2020-01-01

该研究利用三种MYH9相关疾病(MYH9-RD)小鼠模型及体外实验,探究巨核细胞(MK)在骨髓中的分布、对基质细胞衍生因子1的趋化性、NMIIA活性及双极丝组装。结果显示不同MYH9-RD突变均抑制MK在骨髓中的迁移,但不影响双极丝形成,且黏附表型和NMIIA收缩活性因突变而异。结论认为MYH9-RD突变通过多种机制损害MK趋化性,破坏其向血管的迁移,影响前血小板释放,导致巨核细胞性血小板减少。

要点

  • 不同MYH9-RD突变均抑制巨核细胞在骨髓中的迁移,但不影响双极丝形成。
  • MYH9-RD突变导致黏附表型和NMIIA收缩活性呈现分化。
  • MK趋化性受损是MYH9-RD巨核细胞性血小板减少的新机制。

核心结论

  • MYH9-RD突变通过多种机制损害巨核细胞趋化性,破坏其向血管的迁移,影响前血小板释放,导致巨核细胞性血小板减少。

研究设计与样本

  • 使用三种MYH9-RD小鼠模型(NMIIAR702C+/-GFP+/-、NMIIAD1424N+/-和NMIIAE1841K+/-)及体外实验。

主要发现

  • 不同MYH9-RD突变抑制巨核细胞在骨髓中的迁移,但不影响双极丝形成。
  • 不同突变导致黏附表型和NMIIA收缩活性出现分化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Megakaryocytes (MKs), the precursor cells for platelets, migrate from the endosteal niche of the bone marrow (BM) toward the vasculature, extending proplatelets into sinusoids, where circulating blood progressively fragments them into platelets. Nonmuscle myosin IIA (NMIIA) heavy chain gene (MYH9) mutations cause macrothrombocytopenia characterized by fewer platelets with larger sizes leading to clotting disorders termed myosin-9-related disorders (MYH9-RDs). MYH9-RD patient MKs have proplatelets with thicker and fewer branches that produce fewer and larger proplatelets, which is phenocopied in mouse Myh9-RD models. Defective proplatelet formation is considered to be the principal mechanism underlying the macrothrombocytopenia phenotype. However, MYH9-RD patient MKs may have other defects, as NMII interactions with actin filaments regulate physiological processes such as chemotaxis, cell migration, and adhesion. How MYH9-RD mutations affect MK migration and adhesion in BM or NMIIA activity and assembly prior to proplatelet production remain unanswered. NMIIA is the only NMII isoform expressed in mature MKs, permitting exploration of these questions without complicating effects of other NMII isoforms. Using mouse models of MYH9-RD (NMIIAR702C+/-GFP+/-, NMIIAD1424N+/-, and NMIIAE1841K+/-) and in vitro assays, we investigated MK distribution in BM, chemotaxis toward stromal-derived factor 1, NMIIA activity, and bipolar filament assembly. Results indicate that different MYH9-RD mutations suppressed MK migration in the BM without compromising bipolar filament formation but led to divergent adhesion phenotypes and NMIIA contractile activities depending on the mutation. We conclude that MYH9-RD mutations impair MK chemotaxis by multiple mechanisms to disrupt migration toward the vasculature, impairing proplatelet release and causing macrothrombocytopenia.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Pal K, Nowak R, Billington N, et al. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease. Blood. 2020. PMID: 32315395. doi:10.1182/blood.2019003064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。